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Aging-induced cardiac dysfunction is a prominent feature of cardiac aging. Heat shock protein 27 (HSP27) protects cardiac function
against ischemia or chemical challenge. We hypothesized that HSP27 attenuates cardiac aging. Transgenic (Tg) mice with cardiacspecific expression of the HSP27 gene and wild-type (WT) littermates were employed in the experiments. Echocardiography
revealed a significant decline in the cardiac function of old WT mice compared with young WT mice. In striking contrast, the
aging-induced impairment of cardiac function was attenuated in old Tg mice compared with old WT mice. Levels of cardiac aging
markers were lower in old Tg mouse hearts than in old WT mouse hearts. Less interstitial fibrosis and lower contents of reactive
oxygen species and ubiquitin-conjugated proteins were detected in old Tg hearts than in old WT hearts. Furthermore, old Tg hearts
demonstrated lower accumulation of LC3-II and p62 than old WT hearts. Levels of Atg13, Vps34, and Rab7 were also higher in old
Tg hearts than in old WT hearts. Additionally, old Tg hearts had higher levels of PINK1 and Parkin than old WT hearts, suggesting
that mitophagy was activated in old Tg hearts. Taken together, HSP27 alleviated cardiac aging and this action involved antioxidation
and mitophagy activation.

1. Introduction
Intrinsic cardiac aging is defined as slowly progressive
functional declines and structural changes with age, in the
absence of major cardiovascular risks such as hypertension,
diabetes, hypercholesterolemia, and smoking [1, 2]. However,
intrinsic cardiac aging can increase the vulnerability of the
heart to both endogenous and exogenous stressors, ultimately
increasing cardiovascular mortality and morbidity in elderly
individuals [1, 2]. Therefore, interventions to combat cardiac
aging not only will improve the healthspan of the elderly,
but also can extend their lifespan by delaying cardiovascular
disease-related deaths [3].
The phenotypes of the aging heart have been well characterized; however, the molecular mechanisms underlying cardiac aging are not fully understood [3]. Studies indicate that

the pathogenesis of cardiac aging involves multiple molecular
mechanisms, including oxidative stress, impaired autophagy,
metabolic changes, dysregulated calcium homeostasis, and
activation of neurohormonal signaling [3, 4]. Indeed, the
reactive oxygen species (ROS) content significantly increases
in the aged heart, while mitochondrial overexpression of
catalase (an important antioxidative enzyme) improves the
aging-induced decline in cardiac function and prolongs the
lifespan of mice [5, 6]. Intracellular ROS in the aged heart are
mainly generated from damaged mitochondria [1]. In normal
conditions, damaged mitochondria are selectively degraded
through autophagy, or mitophagy, a term coined by Lemasters [1, 7]. Unfortunately, autophagy is progressively impaired
over time [8].
Heat shock protein 27 (HSP27) is an ubiquitously
expressed member of the small heat shock protein subfamily
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with a molecular weight of 27 kDa in humans and 25 kDa
in rodents. Studies demonstrated the involvement of HSP27
in various biological functions, including the responses to
oxidative stress, heat shock, and hypoxic/ischemia injury [9,
10]. Of particular interest to this study, we and others showed
that overexpression of HSP27 protects cardiac function
against cardiac injuries induced by ischemia/reperfusion,
myocardial infarction, inflammation, and doxorubicin [9,
11–13]. The mechanisms that contribute to cardioprotection
by HSP27 involve the antioxidative capacity, suppression of
inflammatory responses, improvement of cardiomyocyte survival, and activation of autophagy and mitochondrial activity
[9, 11–17]. It is possible, therefore, that overexpression of
HSP27 protects the heart from aging-induced injury.
In this study, we examined the effects of HSP27 on
cardiac aging using transgenic (Tg) mice with cardiacspecific expression of HSP27. We observed an improvement
in cardiac function and decreases in the levels of cardiac aging
markers in old Tg mice compared with age-matched wildtype (WT) controls. This action of HSP27 involves the antioxidative capacity and activation of mitochondrial autophagy
(mitophagy). Our results suggest that management of HSP27
expression may serve as an alternative intervention to alleviate cardiac aging.

2. Materials and Methods
2.1. Antibodies and Reagents. A primary antibody against
HSP27 was obtained from Stressgen (Victoria, British
Columbia, Canada). Antibodies against p16, p53, Atg13, Nix,
phosphor-p53 (Ser15), p21, and GAPDH were obtained from
Bioworld Technology Inc. (Louis Park, MN). Antibodies
against LC3, p62, Rab7, and Vps34 were from Cell Signaling Technology (Beverly, MA). Antibodies against Parkin,
PINK1, and BNIP3 were from Abcam (Cambridge, MA). An
antibody against ubiquitin was from Santa Cruz Biotechnology (Dallas, TX). An antibody against dinitrophenyl was
from Sigma (Saint Louis, MO). A BCA protein assay kit
was obtained from Pierce (Rockford, IL). 2 ,7 -Dichlorofluorescein (DCFH) was obtained from Merck (Darmstadt,
Germany).
2.2. Animals. Tg mice with cardiac-specific expression of
the human HSP27 gene (HSP27 Tg) driven by the 𝛼-MHC
promoter were developed using mice with a CBA/BL6 genetic
background and back-crossed with C57BL/6 mice for more
than ten generations as described previously [9, 13]. In the
experiments, 24-month-old HSP27 Tg mice and gendermatched WT littermates served as old mice. In echocardiographic measurements, 2-month-old HSP27 Tg mice and
gender-matched WT littermates served as young controls.
Mice were bred and maintained at the Model Animal
Research Center of Nanjing University and maintained in the
Animal Laboratory Resource Facility at Nanjing University.
All the experiments were performed in compliance with the
Guide for the Care and Use of Laboratory Animals published
by the US National Institutes of Health (NIH Publication, 8th
Edition, 2011). The animal care and experimental protocols
were approved by the Nanjing University Committee on
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Animal Care. All experiments were performed in compliance
with the international guidelines on the ethical use of animals.
2.3. Echocardiography. Two-dimensional echocardiographic
measurements were performed using the Vevo 770 system
equipped with a 35 MHz transducer (Visualsonics, Toronto,
Canada) as in our previous methods [18]. Mice were
anaesthetized by inhalation of 1.5–2% isoflurane. The measurements were performed by an observer blinded to the
treatment. The parameters were obtained in M-mode tracings
at the papillary muscle level or pulse doppler evaluation of
the bicuspid valve and averaged using at least five continuous
cardiac cycles.
2.4. Masson’s Trichrome Staining. Heart tissues at the papillary muscle level were collected for paraffin sectioning. Masson trichrome staining was used to analyze fibrosis according
to previously described methods [18]. The staining was
observed using a microscope at a magnification of 400x. The
percentage areas of fibrosis in the ventricular myocardium
were measured using a software program (Olympus, Japan).
2.5. DCFH Assay. ROS levels were measured using the
fluorescent indicator DCFH, as previously described [9, 19].
When DCFH is added to a tissue homogenate, ROS in the
homogenate will lead to the oxidation of DCFH, producing
the fluorescent product DCF. In our experiments, 1 𝜇M
DCFH was incubated in a volume of 1 mL containing 10 𝜇g
of cardiac cytosolic proteins, and fluorescence was recorded
following incubation for 1 h using a fluorometer (Synergy
HT, BIO-TEK) at an excitation wavelength of 485 nm and an
emission wavelength of 535 nm.
2.6. Protein Carbonylation. Ventricular tissues were homogenized in lysis buffer (0.3 M sucrose, 0.03 M nicotinamide, and
0.02 M EDTA, pH 7.4) and centrifuged at 10,000 ×g for 5 min
at 4∘ C. A volume of 500 𝜇L containing 100 𝜇g of cytosolic proteins was incubated with 2 mM DNPH in the dark for 1 h. The
DNPH-treated proteins were used to detect protein carbonylation by Western blotting.
2.7. Immunofluorescence Staining. Hearts were harvested,
fixed in 4% paraformaldehyde overnight, and processed
for paraffin-embedded sectioning. The sections were then
dewaxed, rehydrated, subjected to antigen retrieval, and
blocked. Subsequently, the sections were incubated with the
appropriate primary antibodies at 4∘ C overnight, followed by
FITC- or Cy3-conjugated secondary antibodies for 60 min
at room temperature. 𝛼-actinin was used to indicate cardiomyocytes. Hoechst 33342 was used to counterstain nuclei.
The staining was observed and images were captured using a
fluorescence microscope at a magnification of 400x. In LC3-II
staining experiments, LC3-II granules were counted and
expressed as the number of LC3-II dots per mm2 of myocardial tissues.
2.8. Western Blotting. Hearts were collected from 24-monthold mice. Western blotting of these samples was performed
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Figure 1: HSP27 alleviates the aging-induced decline of cardiac function. (a) Expression of HSP27 in the hearts of HSP27 Tg mice. The hearts
were collected from adult WT and Tg mice. Protein extracts were prepared for immunoblot analysis against HSP27. The blots against GAPDH
served as loading controls. Note that the primary antibody against HSP27 had no cross-reaction with murine homologue of HSP27. 𝑛 = 3
per group. (b) Representative images of pulse doppler of the bicuspid valve echocardiography. 𝑛 = 6, 9, 3, and 14 in young WT, young Tg, old
WT, and old Tg groups, respectively. (c) E/A ratios. ∗ 𝑃 < 0.05 and ∗∗ 𝑃 < 0.01. 𝑛 = 6, 9, 3, and 14 in young WT, young Tg, old WT, and old
Tg groups, respectively. (d) Representative images of M-mode tracing of echocardiography. 𝑛 = 10, 10, 7, and 38 in young WT, young Tg, old
WT, and old Tg groups, respectively. (e) EF, FS, LVVd, and LVVs values. ∗∗ 𝑃 < 0.01. 𝑛 = 10, 10, 7, and 38 in young WT, young Tg, old WT,
and old Tg groups, respectively.

as described in our previous studies [9, 18]. Briefly, cellular
proteins were prepared from ventricular samples, separated
by 10% SDS-PAGE, and transferred onto Immobilon-P
membranes (Millipore). The membranes were probed with
appropriate primary antibodies, followed by incubation with
peroxidase-conjugated secondary antibodies. The signals
were detected by enhanced Pierce chemiluminescence. The
blots for GAPDH served as a loading control. The signals
were quantified by scanning densitometry, and the results
from each experimental group were expressed as relative
integrated intensity compared with that of controls.
2.9. Statistical Analysis. Data are presented as mean ± standard deviation. Groups were compared using Student’s twotailed unpaired 𝑡-test or one-way analysis of variance followed
by a post hoc procedure (Tukey’s test) for multiple range, as
appropriate, with SPSS 13.0 software (SPSS Inc., Chicago, IL).
Statistical significance was set at 𝑃 < 0.05.

3. Results
3.1. HSP27 Alleviates the Aging-Induced Decline in Cardiac
Function. To evaluate the roles of HSP27 in cardiac aging, we
generated Tg mice expressing the human HSP27 gene. Successful expression of the transgene was confirmed by Western
blot analysis, which demonstrated abundant expression of
HSP27 in Tg mouse hearts, but not in WT controls (the antibody against HSP27 did not cross-react with murine HSP25)
(Figure 1(a)).
The decline in cardiac function is a hallmark of cardiac
aging [20]. Therefore, we examined cardiac performance
using two-dimensional echocardiography in old (24-monthold) and young (2-month-old) mice. Cardiac diastolic function was reflected by the ratio of peak early to late diastolic filling velocity (E/A ratio). Old WT mice demonstrated a significant decrease in the E/A ratio by 37.5% compared with young
WT mice (𝑃 < 0.01) (Figures 1(b) and 1(c)). Furthermore,
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Figure 2: HSP27 decreases the expression of p16 and p53 in hearts of old mice. The hearts were collected from 24-month-old mice. Protein
extracts were prepared for immunoblot analysis against p16 and p53. The blots against GAPDH served as loading controls. ∗∗ 𝑃 < 0.01 versus
WT controls. 𝑛 = 3 per group.
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Figure 3: HSP27 reduces fibrosis deposition in interstitial myocardium of old mice. The hearts collected from 24-month-old mice were
prepared for paraffin-embedded sectioning. Masson’s trichrome staining was performed on the sections to evaluate the fibrosis (indicated
by arrows). Higher magnification images of the boxed areas are shown in the down panels. Representative images from three independent
experiments are shown (a). The quantification of fibrosis was shown (b). ∗∗ 𝑃 < 0.01 versus WT controls. 𝑛 = 3 per group.

the E/A ratio was decreased by 15.9% in old Tg mice
compared with young Tg controls (𝑃 < 0.05). However,
the aging-induced decrease in the E/A ratio was significantly
attenuated by 37.4% in Tg mice compared with WT mice
(𝑃 < 0.05).
Cardiac systolic function was reflected by ejection fraction (EF), fraction shortening (FS), and left ventricular (LV)
volumes at end-diastolic and end-systolic phases (LVVd
and LVVs, resp.). Old WT mice demonstrated significant
decreases in EF (40.0%) and FS (45.9%) and increases in
LVVd (67.4%) and LVVs (181.0%) compared with young WT
mice (𝑃 < 0.01) (Figures 1(d) and 1(e)). By contrast, EF, FS,
and LVVd remained normal in old Tg mice compared with
young Tg controls. Compared with old WT mice, EF and FS
were significantly increased and LVVd and LVVs were significantly decreased in old Tg mice (𝑃 < 0.01).
The LV mass was significantly higher in both old WT
mice (85.7%) and old Tg mice (84.7%) than in their genotypematched young controls (𝑃 < 0.01). However, the LV mass

did not differ between old WT and old Tg mice. The heart rate
did not differ between the young and old groups (Figure 1(e)).
3.2. HSP27 Decreases the Levels of Aging Markers (p53 and
p16) in the Myocardium of Old Mice. The cell cycle regulators
p16 and p53 play important roles in cellular senescence and
therefore serve as aging markers [21, 22]. Therefore, the
expression levels of p16 and p53 were examined in hearts of
old mice. The results of immunoblot analysis are shown in
Figure 2(a). Levels of p16 and p53 were significantly reduced
by 46.5% and 49.4%, respectively, in hearts of old Tg mice
compared with hearts of old WT mice (𝑃 < 0.01).
Expression of p21 is regulated by p53. Hearts of old Tg
mice demonstrated a significantly lower level of p21 than
hearts of old WT mice (𝑃 < 0.01) (Figure 2(a)).
To determine the activation of p53, we examined the
phosphorylation level of p53 at Ser15 (p-p53). The p-p53
level was significantly lower in hearts of old Tg mice (53.0%)
than in hearts of old WT mice (𝑃 < 0.01) (Figure 2(a)).
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Figure 4: HSP27 decreases ROS contents in the hearts of old mice. The hearts were collected from 24-month-old mice. DCFH assay was
performed to evaluate intracellular ROS contents. The relative contents of ROS were expressed as the arbitrary units per 𝜇g protein. ∗∗ 𝑃 < 0.01
versus WT controls. 𝑛 = 3 per group.

To determine whether the activation of p53 occurred in
cardiomyocytes, we performed fluorescence immunohistochemistry of cardiac tissues. Positive staining of p-p53 was
localized in the nuclei of cardiomyocytes in the hearts of both
old WT and old Tg mice (Figure 2(b)).
3.3. HSP27 Attenuates Fibrosis in the Interstitial Myocardium
of Old Mice. Compromised diastolic function is associated with myocardial interstitial fibrosis [23]. We examined
myocardial fibrosis in old mice using Masson’s trichrome
staining. Obvious fibrosis was observed in the myocardial
interstitium of old WT mice (indicated by arrows) (Figures
3(a) and 3(b)). By contrast, there was significantly less fibrosis
in old Tg mouse hearts than in old WT mouse hearts. Fibrosis
was significantly reduced by 76.2% in old Tg mouse hearts
compared with old WT mouse hearts (𝑃 < 0.01).
3.4. HSP27 Decreases the ROS Content in the Myocardium
of Old Mice. ROS are one of the critical players in the
development of cardiac aging [1]. To determine whether ROS
are involved in the protective effect of HSP27 against the
aging-induced decline in cardiac function, we measured ROS

contents in the myocardium of old mice. The ROS content
was 2038.6 and 752.4 units in old WT and old Tg mouse
hearts, respectively (Figure 4(a)). Therefore, hearts of old Tg
mice demonstrated a significantly lower ROS content (by
63.1%) than old WT mouse hearts (𝑃 < 0.01).
Protein carbonylation was also examined in hearts of old
mice. Protein carbonylation was significantly lower in hearts
of old Tg mice (46.1%) than in hearts of WT mice (𝑃 < 0.01)
(Figure 4(b)).
3.5. HSP27 Decreases the Accumulation of LC3-II and p62
in Old Hearts. Activation of mitochondrial autophagy
(mitophagy) alleviates cardiac aging [24]. We first examined LC3 conversion and p62 protein degradation, two
widely used markers of autophagic flux [25], in hearts by
immunoblot analysis. The level of LC3-II was significantly
decreased by 38.7% in old Tg mouse hearts compared with
old WT mouse hearts (𝑃 < 0.01) (Figure 5(a)). Immunostaining of LC3-II confirmed the observation made in
immunoblot analysis (Figure 5(b)). By contrast, the p62
protein level was reduced by 59.0% in old Tg mouse hearts
compared with old WT mouse hearts (𝑃 < 0.01). These data
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Figure 5: HSP27 increases autophagic markers in the hearts of old mice. The hearts were collected from 24-month-old mice. Protein extracts
were prepared for immunoblot analysis against LC3 and p62 (a) and against Atg 13, Vps34, and Rab7 (b). The blots against GAPDH served
as loading controls. ∗∗ 𝑃 < 0.01 versus WT controls. 𝑛 = 3 per group.

suggest that autophagic flux was significantly higher in old Tg
mouse hearts than in old WT mouse hearts.
Atg13, Vps34, and Rab7 play important roles in the formation and maturation of autophagosomes [26–28]. Hearts of
old Tg mice demonstrated significant increases in the levels of
Atg13 (112.7%), Vps34 (68.5%), and Rab7 (138.4%) compared
with hearts of old WT mice (𝑃 < 0.01) (Figure 5(c)).
3.6. HSP27 Increases PINK1 and Parkin Expression in Old
Hearts. PINK1 and Parkin are important for mitophagy
induction [29]. The levels of PINK1 and Parkin were increased
by 57.1% and 60.5%, respectively, in hearts of old Tg mice
compared with hearts of old WT mice (𝑃 < 0.01) (Figure 6).
The mitophagy receptors BNIP3 and Nix were also examined

by immunoblot analysis. The results demonstrated a significantly higher level of BNIP3 in hearts of old Tg mice
compared with hearts of old WT mice (𝑃 < 0.05). The Nix
levels were comparable between the two genotypes.
3.7. HSP27 Reduces the Content of Ubiquitin-Conjugated
Proteins. Autophagy is an important approach for the degradation of ubiquitin-conjugated proteins and damaged organelles including mitochondria [30]. We examined the levels
of ubiquitin-conjugated proteins. Hearts of old Tg mice
exhibited significantly lower levels of protein ubiquitination
(76.2%) than hearts of old WT mice (𝑃 < 0.01) (Figure 7(a)).
As protein loading controls, the SDS-PAGE gel was stained
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and ∗∗ 𝑃 < 0.01 versus WT controls. 𝑛 = 3 per group.

with Coomassie blue (Figure 7(b)) and the blot was probed
for GAPDH (Figure 7(b)).

4. Discussion
The significant finding of this study is that cardiac-specific
expression of HSP27 attenuated the aging-induced decline
in cardiac function of mice. Reduced expression of cardiac
aging markers, less interstitial fibrosis, and lower levels of
ROS and ubiquitin-conjugated proteins were observed in old
Tg mouse hearts compared with old WT mouse hearts. Moreover, old Tg mouse hearts showed significantly decreased

accumulation of LC3-II and p62 proteins and increased
expression of Atg13, Vps34, Rab7, PINK1, and Parkin compared with old WT mouse hearts. Taken together, these
results suggest that HSP27 alleviates cardiac aging and that
this action involves antioxidation and mitophagy activation.
Cardiac aging is associated with compromised cardiac
function. In humans, the LV early diastolic filling rate
progressively slows after the age of 20 years, and therefore by
80 years of age the rate is reduced, on average, by up to 50%
[20]. EF, a parameter indicative of LV systolic function, can
decrease by more than 20% in healthy old individuals [20].
Consistent with this, aged animals also demonstrate
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an impairment in cardiac function [1, 31]. In this study,
cardiac systolic and diastolic functions were reduced and
LV diameters were increased in 24-month-old WT mice.
However, the aging-induced decline in cardiac function and
the enlargement of LV diameter were attenuated in HSP27
Tg mice. These results suggest that HSP27 overexpression
improves the aging-induced impairment of cardiac performance.
While senescence is reflected by phenotypic changes in
functions and structures, the molecular mechanism underlying cellular senescence involves p16- and p53-mediated
pathways [32]. p16 and p53, two important tumor suppressors, mediate senescence through inhibiting the action of
cyclin-dependent kinases, which in turn leads to G1 arrest of
the cell cycle [32]. Indeed, an inverse relationship between
the expression levels of p16/p53 and senescence was well
demonstrated by studies of both humans and animals [32, 33].
Therefore, p16 and p53 are indicated to be signatures of in vivo
senescence [33, 34]. In this study, significantly lower levels
of p16 and p53 expression were detected in old Tg mouse
hearts compared with old WT mouse hearts, suggesting that

aging-induced decline of cardiac function was alleviated by
HSP27 overexpression.
The well-known free radical theory of aging, first proposed by Harman in 1956, posits that intracellular production
of ROS is the major determinant of lifespan [1, 35]. Indeed,
antioxidative interventions, such as overexpression of mitochondrial catalase, significantly improve cardiac systolic and
diastolic functions and decrease protein oxidative damage
in aged mice [36]. Moreover, antioxidation reduces the
expression of p16 and p53 [37, 38]. In this study, old Tg mouse
hearts exhibited significantly lower levels of ROS and protein
carbonylation than old WT mouse hearts. Supporting this,
we and others revealed that HSP27 possesses an antioxidative
capacity in myocytes and other cells [13, 39]. Taken together,
our results suggest that antioxidation was involved in the
protective effect of HSP27 against aging-induced decline of
cardiac function.
Autophagy is an evolutionarily conserved process
involved in the degradation of damaged proteins, mitochondria, and other organelles [40]. The intracellular accumulation of damaged macromolecules and organelles is a feature
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common to all aged cells [41]. The postmitotic nature of
cardiomyocytes makes these cells especially prone to the
accumulation of macromolecular and organellar oxidative
damage over the lifetime, which means that more autophagic
activation is required to clean up this harmful cellular
“garbage” in order to maintain cardiomyocyte homeostasis
[1]. Unfortunately, autophagic activity in cardiomyocytes
declines with age, while impaired autophagy has multiple
consequences including decreased contractile function and
increased arrhythmia risk [42, 43]. Evidence suggests that
stimulation of autophagy via genetic deletion of endothelin
receptor A rescues the aging-induced impairment of cardiac
contractile dysfunction [43]. In this study, we observed
increased activation of autophagy, which was reflected by
decreased accumulation of LC3 and p62, in old HSP27
Tg mouse hearts compared with old WT mouse hearts.
Collectively, these data suggest that autophagic activation is
involved in the protective effect of HSP27 against cardiac
aging.
Mitophagy refers to selective autophagy for mitochondrial degradation. Mitochondria are both the main source
of ROS generation and targets of ROS attack. Due to the
high reliance of cardiomyocytes on mitochondrial energy
metabolism, the heart is exposed to a high burden of ROS
throughout the lifetime [1]. Activation of PINK1 and Parkin
plays a critical role in turnover of damaged mitochondria
through mitophagy. PINK1 kinase activity and its mitochondrial localization are prerequisites for inducing translocation
of the E3 ligase Parkin to depolarized mitochondria. Subsequently, Parkin mediates the formation of two distinct polyubiquitin chains to recruit autophagy receptors [44]. Thus,
PINK1 signals mitochondrial dysfunction to Parkin, and
Parkin promotes the elimination of damaged mitochondria.
Moreover, p53 inhibits Parkin-mediated mitophagy [45]. In
this study, we observed significant increases in PINK1 and
Parkin levels in old Tg mouse hearts compared with old WT
mouse hearts. By contrast, a lower level of p53 was detected
in old Tg mouse hearts compared with old WT mouse hearts.
Taken together, our data suggest that activation of mitophagy
contributes to the alleviation of cardiac aging by HSP27.
In summary, our data provide functional links between
HSP27 expression and improvement of the aging-induced
decline in cardiac function, which suggests that management
of HSP27 expression serves as a potential intervention for
alleviation of cardiac aging.
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